Terms: = Lung cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Staging
5 results:
1. Clinicopathological analysis of clinically occult extrapulmonary lymphangioleiomyomatosis in intra-pelvic and para-aortic lymph nodes associated with pelvic malignant tumors: A study of nine patients.
Uehara K; Kawakami F; Hirose T; Morita H; Kudo E; Yasuda M; Märkl B; Zen Y; Itoh T; Imai Y
Pathol Int; 2019 Jan; 69(1):29-36. PubMed ID: 30688413
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease?
Remo A; Zanella C; Parcesepe P; Greco F; Pancione M; Zapparoli MM; Manfrin E; Micheletto C
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):33-38. PubMed ID: 32476934
[TBL] [Abstract] [Full Text] [Related]
3. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract] [Full Text] [Related]
4. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in lam pathogenesis.
Yu J; Henske EP
Lymphat Res Biol; 2010 Mar; 8(1):43-9. PubMed ID: 20235886
[TBL] [Abstract] [Full Text] [Related]
5. Restrictive lung disease in pregnancy.
King TE
Clin Chest Med; 1992 Dec; 13(4):607-22. PubMed ID: 1478021
[TBL] [Abstract] [Full Text] [Related]
